Navigation Links
Lo studio EXAMINE della Takeda sulla sicurezza cardiovascolare di alogliptin in aggiunta alla terapia standard ha soddisfatto l'endpoint primario di non inferiorità rispetto al placebo dimostrando che non si verifica nessun incremento del rischio ca
Date:9/17/2013

e del glucosio nei pazienti diabete ad elevato rischio di patologie cardiovascolari," ha dichiarato William B. White, MD, FASH, FAHA, FACP, ricercatore principale dello studio EXAMINE. "Considerato il concetto su cui è stato costruito lo studio EXAMINE e la popolazione a elevato rischio valutata, questi risultati forniscono importanti informazioni ai medici che curano pazienti diabetici affetti da malattia coronarica."

Lo studio globale EXAMINE costituisce una valutazione importante poiché prende in esame la sicurezza cardiovascolare in pazienti di cui è noto l'elevato rischio di malattie cardiovascolari (CVD), causa principale di condizioni patologiche e mortalità nella popolazione di pazienti affetti da diabete di tipo 2. EXAMINE, uno studio clinico globale, di grandi dimensioni, randomizzato, in doppio cieco, controllato verso placebo, è stato concepito per valutare la sicurezza cardiovascolare del trattamento con alogliptin in aggiunta alla terapia standard, rispetto al placebo in aggiunta alla sola terapia standard, in pazienti affetti da diabete di tipo 2 e con un ACS (sindrome coronarica acuta) recente.

Nel corso dello studio EXAMINE, i pazienti sono stati assegnati a random al gruppo che sarebbe stato trattato con alogliptin o a quello che sarebbe stato trattato con placebo in aggiunta ai medicinali normalmente previsti per il trattamento del diabete e delle malattie cardiovascolari. 5.380 pazienti sono stati assegnati a random e sono stati seguiti per un tempo mediano di 18 mesi e per un tempo massimo di 40 mesi. Il tasso di interruzioni anticipate del trattamento in studio è stato simile nel gruppo trattato con alogliptin e in quello trattato con il placebo. I pazienti sono stati curati secondo livelli elevati di standard terapeutico del diabete di tipo 2 e dei fattori di rischio cardiovascolari.

"Il disegno dello studio EXAMINE e soprattutto i risultati rilevati per la sicure
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anthony Creed Joins DDSTUDIO As GM, Experience Design
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
4. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
5. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
6. River City Laser Tattoo Removal Studio Offers Grand Opening Discounts on Treatments Using the Astanza Revolution Laser
7. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
8. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
9. Study Examines Smart Pharma Strategies for Effective Messaging around New Products and the Medical Conditions they Treat
10. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
11. The Food Journal Examines Dietary Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 ... nephrologists report awareness of the U.S. Food and Drug ... Pharma,s new phosphate binder Velphoro, which was approved by ... hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 ...
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... , , , , , SAN ... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and ... ALKS ) today announced positive results from a head-to-head ... BYETTA® (exenatide) injection taken twice daily, in patients with type ...
... , , LONDON, Dec. 14 The 2009 Frost ... Market is conferred on SonoScape. The award recipient has effectively ... pricing, and portability - and introduced the S8 hand-carried ultrasound ... compares with that of a regular, high-end, cart-based echo ultrasound ...
Cached Medicine Technology:Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3
(Date:7/10/2014)... Washington, D.C. (PRWEB) July 10, 2014 ... Alliance for Bangladesh Worker Safety announced today it will ... up to four months’ wages for workers displaced as ... , To date, Alliance inspections have resulted in the ... found in all five cases, raising immediate safety concerns. ...
(Date:7/10/2014)... Best Drug Rehabilitation , which offers ... by during a stay in rehab can make ... process is successful, has launched an inspiring “Success ... . , The new Success Stories section contains ... Drug Rehabilitation graduates who wanted to help others ...
(Date:7/10/2014)... of electronic health record becomes widespread across the United ... Affordable Care Act, the quantity of clinical data that ... also dramatically increase. Additionally, experts in healthcare have ... quantities of data for the purpose of gleaning insights ... patient care a process that is known as ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July ... the hot flashes that often accompany menopause, new research suggests. ... percent of menopausal women, said Dr. Taraneh Shirazian, an assistant ... Icahn School of Medicine at Mount Sinai Hospital in New ... 10 hot flashes a day, and she added that hot ...
(Date:7/10/2014)... (EMS) responders felt better prepared to respond to an ... to a new study in the journal Prehospital ... to specifically examine the EMS provider comfort level with ... not yet been neutralized or working with law enforcement ... Columbine High School shooting, the Virginia Tech campus shooting, ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety to Double Compensation for Displaced Factory Workers; Members Vote to Extend Wage Benefits from Two to up to Four Months 2Health News:Best Drug Rehabilitation Launches New Success Stories Section of Website 2Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Active shooter training increases comfort level of emergency responders 2
... working to ... Oct. 15 More than half of the children in,Indianapolis ... University School of Dentistry mobile project had moderate or,severe dental ... by the,university and funded in part by a grant from ...
... mathematician who has applied mathematical modeling techniques to elucidate the ... methods to ascertain the players most deserving of major league ... awards. Bukiet, a popular NJIT math professor, dives annually ... game, but also for his love of teaching and math. ...
... DUBLIN, Ohio, Oct. 15 Foresight Corporation ... Debra Strickland has joined the,company,s Development division ... http://www.newscom.com/cgi-bin/prnh/20081015/CLW134 ), In this role, ... customers to,propose and design new technical solutions, ...
... 15 deCODE genetics,(Nasdaq: DCGN ) today ... review of,its long-term business strategy. Over the past ... chemistry, structural biology and,human genetics to develop product ... diagnostics. The goal of this strategic,review is to ...
... Thanks Donor Family for New Hand, LOUISVILLE, Ky., ... transplant recipient headed home,yesterday (Oct. 14) to Upland, California, ... new right hand during a 14-hour surgical,procedure performed by ... on July 12, 2008 at Jewish Hospital., "I ...
... Cenegenics Education and Research Foundation partnered with two recognized ... of Medicine to examine testosterone and/or human growth hormone ... body composition and quality of life. Favorable findings from ... Journal of Multidisciplinary Healthcare, part of Dove Open Access. ...
Cached Medicine News:Health News:SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay 2Health News:Using math model, NJIT professor names MVP and Cy Young award contenders 2Health News:Using math model, NJIT professor names MVP and Cy Young award contenders 3Health News:Debra Strickland joins Foresight Corporation in time for HIPAA 5010 Mandate 2Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 2Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 3Health News:deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business 4Health News:Fourth Hand Transplant Recipient Heads Home to California 2Health News:Hormone Normalization Shows Encouraging Effects In Documented Clinically Deficient Men/Women 2Health News:Hormone Normalization Shows Encouraging Effects In Documented Clinically Deficient Men/Women 3
... when it comes to superior immobilization and cervical ... job., ,You already know that the most ... of the c-spine. But what you may not ... Medical's NECLOC ®: provides superior immobilization over the ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... The B3 Triplanar hip joint ... Flexion - extension, abduction - ... on our Boston Post-Op Hip ... our custom Hip Spicas in ...
... Impact is the most significant advance in walker design ... unique design where the weight bearing surfaces of the ... impact is absorbed at the heel strike. The footbed ... the foot for added comfort and stability. , ...
Medicine Products: